Ophthalmology

Top Story

Speaker delivers DRCR.net update at Angiogenesis meeting

Speaker delivers DRCR.net update at Angiogenesis meeting
February 8, 2016

MIAMI — Harry W. Flynn Jr., MD, discussed the newly published and continuing trials of the Diabetic Retinopathy Clinical Research Network at Angiogenesis, Exudation, and Degeneration 2016.

Protocol S, which was recently published, showed that intravitreal Lucentis (ranibizumab, Genentech) was not inferior to panretinal photocoagulation for diabetic macular edema and resulted in better visual acuity over 2 years. The ranibizumab group had a higher chance of a 10-letter score improvement or better, while the PRP group had a higher chance of visual acuity worsening by 10 letters or more, as well as a higher chance for pars plana vitrectomy and vitreous hemorrhage.

The Young OphthalmologistFrom OSN EuropePublication Exclusive

Practice is key to learning surgery

Ocular Surgery News Europe Edition, February 2016
Jack S. Parker, MD
A major concern for all ophthalmic trainees is the progression of our surgical skills and abilities. The best methods for surgical training and optimizing performance…
From OSN Europe

Home-monitoring device helps to detect CNV earlier

Ocular Surgery News Europe Edition, February 2016
Home monitoring with a preferential hyperacuity perimetry device may allow for early detection of choroidal neovascularization-related changes in patients with early…
From OSN Europe

FEMCAT study evaluating value of femtosecond cataract surgery

Ocular Surgery News Europe Edition, February 2016
Almost 1,800 subjects have been enrolled in the French FEMCAT study evaluating the clinical value and cost-effectiveness of femtosecond laser-assisted cataract surgery…
Meeting News CoverageVideo

VIDEO: Surgeon recommends iStent device prior to cataract surgery

February 8, 2016
WAIKOLOA, Hawaii — At Hawaiian Eye, Con Moshegov, MD, discusses how patients can benefit from the Glaukos iStent device before cataract surgery.
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME

Best of Retina Forum: Focus on the Diabetic Eye

This activity is supported by educational grants from Allergan, Inc. and Regeneron Pharmaceuticals, Inc.

The management of diabetic eye disease has undergone significant changes over the last 18 months. Two steroid implants…
More »
Featured
Meeting News CoverageVideo

VIDEO: Surgeon says physician consulting necessary for drug, device development

February 4, 2016
More »
morganatic-roan